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ABSTRACT: Nimbidin the major bitter principle from oil of seeds of Azadirachta indica A.  
Juss was investigated for various pharmacological actions in a number animal models.  On 
central nervous system it exhibited moderate sedative effect it did not show any significant 
cardiovascular effects in experimental animals.  Autonomic pharmacological studies (in-vitro) 
revealed pronounced anticholinergic antihistaminic (H1-receptor), anti 5 HT and antinicotinic 
activities.  But in-vivo tests did not show any anticholinergic or anti-histaminic  activity.  
Nimbidin possessed moderate diuretic activity and was found to be devoid of local anaesthetic 
and antiandrogenic effects in rodents.  
Introduction 
Nimbidin, the major bitter principle from the 
oil of neem seed (Azadirachta indica seeds) 
kernels has been shown to possess a number 
of medicinal properties.
   Recently we have 
reported that it possessed significant    
antigastric ulcer
2, antiarthritic and anti-
inflammatory
3, analgesic and antipyretic
4 as 
well as hypoglycaemic effects
5  in various 
experimental models.  In the present study, 
efforts were made to explore its other 
potential pharmacological actions in selected 
experimental animal models. 
Materials and Methods 
Nimbidin used in the study has been isolated 
from commercially available neem oil by the 
method of Siddiqui and Mitra.
6  Nimbidin 
was used as colloidal solution of alcohol in 
water (10% v/v) in concentration of 10-20 
mg/ml.  Various pharmacological actions 
were tested by the following methods. 
Effects on Central Nervous System (CNS) 
On grass behavioural effects: Gross 
behavioural, neurologic, autonomic and 
toxic effects were observed as described by 
Irwin
7, at 15, 30, 60, 120 min, and thereafter 
at 6 hourly intervals upto 72 hours in orally 
administered group and 24 hours in i.p. 
group.  Nimbidin was given in graded doses 
of 10-2000 mg/kg (p.o.) and 10-1000 mg 
(i.p) to both albino rats and mice.  Control 
groups received only the vehicle, 10% 
alcohol.  
Potentiation of pentobarbitone hypnosis: 
Pentobarbitone sodium (50mg/kg i.p) was 
injected to groups of 6 male mice (20-25g) 
in each, 30 min after oral administration of 
nimbidin in doses of 20, 40 and 80 mg.kg, Page 88-95 
and the vehicle control group received 10% 
alcohol orally.  The period between the loss 
and return of righting reflex was taken as the 
sleeping time and this was calculated for 
each group and compared. 
Anticonvulsant activity: 
Chemoshock  seizure were induced in 18h 
fasted mice (20-25g) by a single s.c injection 
of metrazol (90 mg/kg) and nimbidin (20 
and 40 mg.kg) was given orally 30 min prior 
to the convulsant. Percentage protection 
afforded was observed and the 
anticonvulsant activity assessed in terms of 
absence of clonic convulsions. 
In rats (100-125g) anticonvulsant 
electroshock seizure pattern test (MES), 
according to the method of Swinyard et 
al18; Nimbidin (20,40 and 80 mg/kg p.p) 
was given one hour prior to the challenge of 
electroshock.  Prevention of tonic extension 
of hind limbs was taken as the evidence of 
anticonvulsant activity.  Phenobarbitone 
sodium 50 and 100mg/kg was the reference 
drug.  
Effects on cardiovascular system (CVS) 
Effect on arterial Blood Pressure (B.P.): 
In mongrel dogs of either sex (10-12 kg) 
anaesthetized with pentobarbital sodium (35 
mg/kg i.v.), nimbidin was administered i.v. 
for its effect on blood pressure and its ability 
to antagonize  Various agonists influencing 
cardiovascular function. Carotid (right) 
blood pressure (B.P.), ECG (lead II) and 
respiration was monitored through     the 
Encardio Rite Polygraph.  Blood pressure 
responses were obtained with adrenaline, 
acetylcholine, histamine and isoprenaline (2 
ug.kg i.v., each), carotid occlusion (CO) for  
45 sec.  and stimulation of peripheral and 
central cut end of the vagus (5V-10/sec. for 
2 sec.) before and after test drug.  Nimbidin 
was injected i.v. through the cannulated 
femoral vein in dose levels of 100 ug to 80 
mg/kg as colloidal solution in 10% alcohol.  
Normal ‘response bracket’ was taken before 
and after the test drug (i.v) as described by 
Smith
9. Hypotensive activity of nimbidin 
when observed was also studied after 
atropinization (Atropine SO4 1.5 mg/kg i.v.) 
and bilateral vagotomy.  Effect of nimbidin 
on nicotine induced (10-20  μg/kg  i.v). 
hypertensive effect was also studied on dog 
B.P. 
Myocardiography: 
Experiment were carried out in selected 
dogs (10-20 kg  body weight) for studying 
the effect of nimbidin (1,  5,  10 and 20 
mg/kg) on the rate and amplitude of 
auricular (left) and ventricular (right) 
contractions.
10 
Isolated  rabbit heart preparations:- were put 
up and the effect of nimbidin on the heart 
rate and amplitude of contraction in-vitro 
was recorded.11 
Continuous heart perfusion of frog (in-situ): 
Contractions of the perfused frog heart was 
recorded on a smoked paper attached to the 
slow moving drum using starling heart lever.  
Nimbidin was injected into the perfusing 
fluid in varying doses (10/ug to 10mg) in a 
constant volume.  Change in the rate, tone 
and force of contractions were recorded.
12 
Chromodacryorrhea test Page 88-95 
Effect of nimbidin (20 and 40 mg/kg) and 
atropine sulfate (3mg/kg) were studied for 
their effect on methacholine –  induced 
chromodacryorrhea in Holtzman male rats.
13 
Treatments were assigned to groups of 6 rats 
and test drugs or the vehicle were injected 
i.p.; 30 min. later, the animals were checked 
for mydriasis and then given methacholine 
(10 mg/kg i.p.). The presence or absence of 
chromodacryorrhea was recorded 10 min.   
After the methacholine administration on 
‘Yes’ or ‘No’ basis.
14 
Gastrointestinal Motility 
Effect on Nimbidin on intestinal transport 
was determined by using the method of 
Macht and Barba-Gosa with modifications.
15 
Nimbidin (20 and 40mg/kg) or carrier 
vehicle (10% alcohol) or atropine (25 
mg/kg) was administered orally to the 
respective groups.  One hour later, the rats 
received a charcoal meal (2 ml/100g body 
weight) consisting of 10% charcoal and 10% 
gum acacia suspended in 0.5% CMC. Ten 
minutes later all animals were sacrificed and 
the distance traversed by the charcoal meal 
was expressed as percent of the total length 
of the small intestine and the results were 
compared statistically. 
Antihistaminic test (in-vivo) 
Nimbidin was evaluated for its ability to 
protect against the lethal toxicity of 
histamine aerosol in guinea pigs
10, 16  in 
various dose levels (20, 40 and 80 mg/kg.) 
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LEGENDS TO ILLUSTRATIONS 
Fig. 1: Showing the anticholinergic and 
antinicotinic (ganglionic blocking ) activities  
of nimbidin on guinea pig ileum. 
Ach –Acetylcholine (1 μg) 5-HT-%-hydroxy 
tryptamine (1 μg) 
Nic – Nicotine  (100  μg)  N-Nimbidin (200 
μg) (con- μg/ml bath fluid) 
Fig.2: Showing antihistaminic effect of 
Nimbidin on g. pig ileum. 
H-Histamine (3 μg) Al-Alcohol (10%), N-
Nimbidin (1 mg) 
Fig.3: Anti-5-HT effect of nimbidin on rat 
uterus (in-vitro) 
5-HT-5-Hydroxytryptamine (50mg) Al-
Alcohol.  N-Nimbidin (200  μg) 
Fig.4: Effect of nimbidin on Histamine. 
H2 – receptors in rat uterus. Page 88-95 
5-HT-5-Hydroxytryptamine (50ng) E.S-
electrical stimulation (100 v,10 m. Sec. 
50/sec, 10 sec) 
H- Histamine, N-Nimbidin. 
Fig.5. Effect of nimbidin on skeletal muscle 
of frog (rectus Abdominis) Ach-
acetylcholine (2 μg) 
 Al-alcohol-10% N-Nimbidin (1&2 mg/ml) 
And the animals observed for respiratory 
distress.  They were considered unprotected 
when they fell on sides with asphyxia 
convulsions. 
Autonomic Pharmacology-Isolated Tissue 
studies 
Gunea pig ileum: Anticholinergic and 
antihistaminic activity. 
Longitudinal contraction of 2cm length of 
guinea pig ileum to alternate doses of 
acetycholine and histamine (1-3 μg/ml) was 
recorded on smoked paper by isotonic 
frontal writing levers (load 1g).  The tissue 
was suspended  in  Krebs  solution at 37
oC 
and bubbled with fresh air, A contact time of 
30s in each 3 min dose cycle was used for 
each agonist.  Dose response curves were 
recorded both before and after contact of 
nimbidin (100 to 500 μg/ml).  Nicotine or 5-
HT act at different receptors of the 
intramural nerve plexus of Auerbach, 
nicotine responses being hexamethononium 
sensitive and 5 –  HT responses 
hexamethonium resistant.  Acetylocholine 
was the control agonist.
17 
Rat ileum-Anti 5-HT activity 
Longitudinal contractions of 2 cm lengths of 
terminal rat ileum to alternate doses of 
acetylcholine and 5 – HT were recorded (1 
μg/ml).  The tissue was suspended in Krebs 
solution at 37
oC.  The agonist contact time 
in each 4 min dose cycle was 30s, the tissue 
being washed three times by over flow 
between doses.  Dose response curves were 
made before and after exposure of the tissue 
to nimbidin (100-500  μg/ml) for one 
minute.
17 
Rat Uterus-Histamine H2-receptor blockade 
and anti 5-HT effects. 
Rat uterus preparation was used to detect a 
histamine H2 receptor blocking potential of 
the test drug as per the method of Patnaik et 
al.
18 
In another set of experiments using isolated 
rat uterine horn in an organ bath containing 
De-Jalon solution, effect of nimbidin in 
antagonizing the 5-hydroxy-tryptamine (5-
HT) induced contractions was studied.   
Estrogen primed rat uterus was taken for the 
study using graded doses of 5-HT 
(10,15,20,25,50 and 100 mg), contractions 
of uterus were elicited at room temperature 
and thereafter test drug (10 μg-1mg/ml) was 
added 1 min before 5-HT and effect of the 
rug on 5-HT induced contractile response 
was observed. 
Effect on skeletal muscle 
To detect whether nimbidin is a peripherally 
acting muscle relaxant or not, isolated frog’s 
rectus abdominis muscle preparation was set 
up as described by Burn.
12 
Diuretic Activity Page 88-95 
Diuretic activity of nimbidin was 
investigated in Holtzman male rats (175-
200g) using the method of Lipschitz et al 
with modifications.
19 The test drug in 20 and 
40 mg/kg as solution in 10% alcohol was 
given orally, and hydrochlorothiazide 2.5 
mg/kg was taken as the standard diuretic for 
comparison.  Control rats received 10% 
alcohol.  The total volume of urine excreated 
in a 5h period was measured.  Urinary 
excretion, diuretic activity  and ionic 
excretion (Na+, K+) in urine were calculated 
for all groups and compared. 
Effect on Fertility 
In females: Preliminary antifertility effect on 
nimbidin (20 and 40 mg/Kg p.o) was 
evaluated in Holtzman female rats of proven 
fertility, by administering from day one (DI) 
of pregnancy to day seven (D7), On D10 
they were laparatomised and uterine horns 
examined for the number and size of 
implants.
20 
In males: To detect the effect of test drug on 
the spermatogenesis and male sex organs, 
the drug was daily fed in dose levels of 25, 
50 and 100mg/kg in groups of fertile male 
albino  rats (125-150g) of Holtzman strain, 
for a period of 6 weeks.  Control group was 
also maintained with the vehicle, 10% 
alcohol for the above period.  At the end of 
medication they were sacrificed, male sex 
organs were collected, weighed, histological 
and biochemical investigations (cholesterol, 
total proteins, fructose and phosphatases) 
were carried out for each group. 
 
Antiantrogenic activity  
In castrated young male rats (60-90g) 
testosterone-phenyl propionate 1 mg/kg was 
given s.c., alone in control group and 
simultaneously with nimbidin (20 and 40 
mg/kg orally, for a period of 7 days 
beginning with one day after castration.  On 
the 8
th  day all rats were killed, seminal 
vesicles, prostate and levator anii were 
dissected out and wet weight noted.   
Inhibition of androgen induced weight gain 
would indicate antiandrogenic activity.
21 
Local Anaesthetic activity 
Surface anaesthesia was tested on the rabbit 
cornea by instilling the test drug as 10% 
alcohol solution into the eye.  Local 
anaesthesia was regarded complete when the 
animal failed to blink in response to all the 6 
bristle touches to corneae.
22 
Infiltration anaethesia – was tested in male 
guinea pigs using the intradermal skin wheal 
test method of Bulbring and Wajda.23 Test 
drug in different concentrations in 0.25 ml 
volume was injected intradermally in shaved 
backs  of guinea pigs in four areas. 
Anaesthesia was regarded complete when 
the animal failed to react to all the 6 pin 
pricks on the site of injection. 
Results  
Effects on Central Nervous system 
On gross behavioural effects: At lower doses 
(upto 100mg/kg) no appreciable gross 
effects were noticed both in rats and mice.  
But from 250 mg/kg onwards nimbidin 
produced a dose dependent mild CNS 
depressant activity in rodents 15 min after   
i.p. injection and 60 min after oral dosing  Page 88-95 
Potentiation of pentobarbitone hypnosis 
Nimbidin in 40 and 80 mg/kg dose levels 
potentiated the sleeping time effect was not 
statistically significant. 
Anticonvulsant activity 
In metazol-induced seizures in mice and 
supramaximal electroshock seizure test in 
rats nimbidin failed to protect animals 
against the clonic an tonic convulsions 
respectively, whereas, phenobarbitone (50 
and 100 mg/kg) exhibited 60% and 80% 
protection. 
Effects on cardiovascular system  
Nimbidin upto 8 mg/kg (i.v) failed to 
produce any effect on B.P., E.C.G and 
respiration in anaesthetized dogs, but from 
10 mg/kg onwards it produced a transient 
fall in B.P which was not blocked by 
atropine or antihistaminics pretreatment.  In 
higher doses  it showed an increase in the 
rate and amplitude of respiration.  Test drug 
also showed a dose-dependent blockade of 
the hypertensive effect of large dose of 
nicotine (20 μg/kg)  
It had no effect on the rate and amplitude of 
both auricular and ventricular contractions 
upto 20 mg.kg in intact dog heart as well as 
in isolated rabbit heart. 
On frog heart (in-situ) nimbidin showed 
bradycardia from 2 mg onward and this 
effect was neither cholinergic nor 
sympatholytic. 
Chromodacryorrhea: Nimbidin did not block 
the methacoline induced chromodacryorrhea 
in rats. 
Gastrointestinal motility: Nimbidin failed to 
influence intestinal transit of charcoal meal, 
whereas atrophine-sulphate decreased the 
translocation of intestinal contents. 
Antihistaminic test (Invivo): it did not 
protect g. pigs against histamine 
aerosolinuced convlusions. 
Autonomic Pharmacology 
There was 50 and 70% blockade of 
acetycholine-induced contractions with 100 
and  200  μg/ml  of  nimbidin  respectively 
(Fig.1). It produced 40% inhibition of 
histamine-induced  (3  μg/ml)  spasms  of  g. 
pig ileum in a concentration of 1 mg/ml bath 
(Fig2). But this blockade was found to be of 
weak, transient and noncompetitive.  
Nimbidin at concentrations of 200 and 500 
μg/ml produced 50 and 90% blockade of the 
spasmogenic effect of nicotine (100 μg/ml) 
in g. pig ileum indicating ganglion blocking 
activity of test drug (Fig.1). 
Nimbidin  (200  μg/ml)  exhibited  50%  and 
80% antagonism of 5 –HT induced spasms 
in rat ileum and rat uterus (Fig.3) 
respectively. 
In electrically stimulated rat uterus nimbidin 
up to 500 μg/ml bath fluid failed to exhibit 
any histamine H2 –  receptor blocking 
activity (Fig.4) 
On frog skeletal muscle preparation, 
nimbidin from 100 μg/ml onwards showed 
antagonism of Ach (2μg/ml) induced spasms 
and with 2 mg/ml dose there was 60% 
inhibition, which was also found to be 
reversible (Fig .5). Page 88-95 
Diuretic activity  
Nimbidin showed only moderate diuretic 
effect (48% urinary excretion at 40mg/kg) as 
compared to that hydrochlorothiazide (94% 
) in rats. 
Effect on fertility 
Nimbidin failed to exhibit any significant 
effect on implantation in proven fertile 
female and supermetogenesis in male rats.   
It was also found to be devoid of any 
antiandrogenic  potential. 
Local anaesthetic activity 
In both test patterns nimbidin did not exhibit 
any local anaesthetic effect in rabbits as well 
as  g. pigs. 
Discussion  
Present investigation on nimbidin, the crude 
bitter principle from neem seeds clearly 
demonstrated that this compound does not 
possess any undesired pharmacological 
actions.  It was observed to have only 
moderate CNS depressant effect as it 
potentiated the pentobarbitone sleeping time 
in mice at 40 and 80 mg/kg dose levels.  But 
it had no anticonvulsant activity in rodents.  
Nimbidin did not show any significant 
cardiovascular effects, but at higher dose 
levels (10 and 20 mg/kg i.v) it exhibited 
partial antinicotinic action in anaesthetized 
dogs predictive of its ganglion blocking 
effect. 
In autonomic pharmacological studies (in-
vitro) nimbidin significantly inhibited the 
spasmogenic action of acetylcholine, 
histamine, nicotine on isolated smooth 
muscles of the G.J tract of g.pigs.  it also 
exhibited anti-5-HT effect on smooth 
muscle preparations of rat.  However the 
drug failed to  exhibit any   effect on the 
normal motility of the gasto-intestinal tract 
in rodents (in-vivo). Similarly this in-vitro 
anticholinergic and antihistaminic effects 
could note demonstrated in in-vivo tests like 
chromodacryorrhea in rats and histamine 
aerosol test in g.  pigs. On the contrary, 
nimbidin exhibited antinicotinic activity in 
both in-Vitro and in-vivo test petterns 
suggestive of the ganglion blocking effect.  
But it was devoid H2-receptor blocking 
action in-vitro.  
Nimbidin showed moderate diuretic activity 
without influencing the ionic concentration.  
It was devoid of any local anaesthetic and 
antifertility effects in rodents.  The 
pronounced  anticholinergic, anti-5-HT and 
antinicotinic effect exhibited by this crude 
compound without any significant CNS or 
CVS effects warrant further detailed 
evaluation before it is being exploited in 
therapy. 
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